Idexx Laboratories | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Abbott USD 6.03B 93M 2024-12
Align Technology USD 696.94M 15.17M 2024-12
Dentsply International USD 455M 40M 2024-12
Dexcom USD 709.3M 115.5M 2024-12
Edwards Lifesciences USD 1.09B 2.1M 2024-12
Fujifilm JPY 334.12B 21.02B 2024-12
Globus Medical USD 393.86M 38.67M 2024-12
Henry Schein USD 993M 0 2024-12
Hologic USD 580.5M 22.8M 2024-12
Idexx Laboratories USD 570.66M 25.38M 2024-12
Insulet USD 430.9M 53.8M 2024-12
Integra LifeSciences USD 265.84M 47.8M 2024-12
Intuitive Surgical USD 1.64B 268.3M 2024-12
Masimo USD 244.7M 18.5M 2024-12
Neogen USD 113.33M 8.4M 2024-11
Patterson Companies USD 320.82M 7.27M 2025-01
ResMed USD 751.28M 34.06M 2024-12
Roche Holding CHF 11.69B 48M 2024-12
Steris USD 610.33M 31.54M 2024-12
Tandem Diabetes Care USD 157.45M 32.8M 2024-12
Teleflex USD 439.92M 9.74M 2024-12
Thermo Fisher Scientific USD 4.82B 494M 2024-12
Zoetis USD 1.61B 79M 2024-12



Idexx Laboratories Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.